At hLAB we provide a biobank with human biospecimens for research. The biospecimens are obtained from a UK-based specialist contract research organisation (hVIVO); the world leader in testing infectious and respiratory disease vaccines and therapeutics using human challenge clinical trials.
Through our research biobank service, we are committed to advancing healthcare through collaborative efforts in key clinical areas. With a focus on vaccine development, immunology, virology, and respiratory disease research, our biobank serves as a vital resource for researchers.
Governed by the UK’s Human Tissue Authority (HTA), we adhere to stringent ethical standards and informed consent protocols, ensuring the utmost respect for patient rights and privacy. Our comprehensive repository houses a diverse range of human biofluids, providing researchers with valuable insights to drive innovation and breakthroughs in these critical fields. By harnessing the power of collaboration and quality clinical information, we are shaping the future of healthcare and improving outcomes for patients worldwide.
In addition, our ethically approved Research Tissue Bank protocol enables us to prospectively collect samples tailored to your research needs.
Ethically approved
Fully consented
Healthy controls
Viral positive samples
Titre data
Full comprehensive donor history
Influenza
Rhinovirus (healthy)
Rhinovirus (Asthma)
RSV
SARS-CoV-2
Uninfected Controls
Nasopharyngeal Swab (NPS)
Plasma
Serum
Nasal Scrape
PAXgene RNA/DNA
Nasosorption Device Eluate
Whole Blood (custom collection)
Custom Collection Swabs (wet/dry)
Other non-invasive biospecimens (for example saliva, urine, sweat etc.)
Understanding the importance of accommodating researchers' timelines and requirements, that is why we are offering adaptable scheduling options to ensure seamless sample collection and delivery. This commitment to flexibility empowers researchers to conduct their studies efficiently and effectively, driving impactful advancements in healthcare research.
Providing customised collections as a distinct advantage within our biobank services. Our tailored approach allows researchers to specify unique parameters for sample procurement, including specialized donor criteria and sample types. This bespoke service ensures that researchers receive precisely the specimens they need to fuel their groundbreaking studies, fostering innovation and progress in healthcare research.
The hLAB facility can also accommodate your samples for either long-term or short-term storage. Our facility is HTA compliant, GCLP certified, and temperature monitored 24/7. Sample storage is one of the most important steps in ensuring the integrity of samples and can significantly impact the success of research. hLAB can provide reliable and certified options and can be your reliable and trusted partner.
hLAB will not profit financially from the research biobank, the collection, storage, maintenance, and transfer of donor information and/or samples represent a significant cost. These costs will be passed on as a service fee (for the collection, processing and storage of the samples) to external collaborators and/or commercial or non-commercial third-party research organisations who use donor information or samples from the research biobank. hVIVO holds the right to waive the service fee at the discretion of the access and governance committee.
The purpose of hVIVO’s research biobank is to provide a resource of Human Biological Samples (HBS) that can support research and development and address unmet needs within the expanding market for HBS. The research biobank will enable new knowledge generation to improve disease management and , improve laboratory testing processes and to aid innovation in the research and discovery of new medicines, using healthy control samples and infected samples in the fields of viral and respiratory medicine. hVIVO has an in depth understanding of UK regulatory and global industry requirements.
